0001209191-22-012156.txt : 20220223
0001209191-22-012156.hdr.sgml : 20220223
20220223160548
ACCESSION NUMBER: 0001209191-22-012156
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220211
FILED AS OF DATE: 20220223
DATE AS OF CHANGE: 20220223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blouse Grant E.
CENTRAL INDEX KEY: 0001869883
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51173
FILM NUMBER: 22663480
MAIL ADDRESS:
STREET 1: C/O CATALYST BIOSCIENCES, INC.
STREET 2: 611 GATEWAY BOULEVARD, SUITE 710
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001124105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562020050
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD., SUITE 710
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-871-0761
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD., SUITE 710
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: TARGACEPT INC
DATE OF NAME CHANGE: 20000919
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-11
0
0001124105
CATALYST BIOSCIENCES, INC.
CBIO
0001869883
Blouse Grant E.
C/O CATALYST BIOSCIENCES, INC.
611 GATEWAY BOULEVARD, SUITE 710
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Scientific Officer
Stock Option (Right to Buy)
0.52
2022-02-11
4
A
0
200000
0.00
A
2032-02-11
Common Stock
200000
200000
D
1/4 of the shares subject to the option will vest on the one-year anniversary of the vesting commencement date of February 11, 2022, and 1/48 of the shares subject to the option will vest on each monthly anniversary of the vesting commencement date thereafter.
/s/ Seline Miller, Attorney-in-Fact for Grant E. Blouse
2022-02-23